{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:09:28Z","timestamp":1793506168587,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,1,30]]},"DOI":"10.1038\/s41388-019-1045-6","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T17:03:03Z","timestamp":1570467783000},"page":"1098-1111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1038","volume":"39","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghe","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","volume":"12","author":"A Wu","year":"2010","unstructured":"Wu A, Wei J, Kong LY, Wang Y, Priebe W, Qiao W, et al. Glioma cancer stem cells induce immunosuppressive macrophages\/microglia. Neuro Oncol. 2010;12:1113\u201325.","journal-title":"Neuro Oncol"},{"key":"1045_CR2","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1158\/0008-5472.CAN-18-2439","volume":"78","author":"MA Morgan","year":"2018","unstructured":"Morgan MA, Canman CE. Replication stress: An Achilles\u2019 heel of glioma cancer stem-like cells. Cancer Res. 2018;78:6713\u20136.","journal-title":"Cancer Res"},{"key":"1045_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1101\/gad.261982.115","volume":"29","author":"JD Lathia","year":"2015","unstructured":"Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203\u201317.","journal-title":"Genes Dev"},{"key":"1045_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/75373","volume":"18","author":"J Alimonti","year":"2000","unstructured":"Alimonti J, Zhang QJ, Gabathuler R, Reid G, Chen SS, Jefferies WA. TAP expression provides a general method for improving the recognition of malignant cells in vivo. Nat Biotechnol. 2000;18:515\u201320.","journal-title":"Nat Biotechnol"},{"key":"1045_CR5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","volume":"16","author":"T Di Tomaso","year":"2010","unstructured":"Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res. 2010;16:800\u201313.","journal-title":"Clin Cancer Res"},{"key":"1045_CR6","doi-asserted-by":"publisher","first-page":"1556080","DOI":"10.1080\/2162402X.2018.1556080","volume":"8","author":"SD Brown","year":"2018","unstructured":"Brown SD, Holt RA. Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome. Oncoimmunology. 2018;8:1556080.","journal-title":"Oncoimmunology"},{"key":"1045_CR7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan N, Furness AJ, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351:1463\u20139.","journal-title":"Science"},{"key":"1045_CR8","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.4049\/jimmunol.151.6.2974","volume":"151","author":"WA Jefferies","year":"1993","unstructured":"Jefferies WA, Kolaitis G, Gabathuler R. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides. J Immunol. 1993;151:2974\u201385.","journal-title":"J Immunol"},{"key":"1045_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1084\/jem.180.4.1415","volume":"180","author":"R Gabathuler","year":"1994","unstructured":"Gabathuler R, Reid G, Kolaitis G, Driscoll J, Jefferies WA. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J Exp Med. 1994;180:1415\u201325.","journal-title":"J Exp Med"},{"key":"1045_CR10","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1158\/1078-0432.CCR-18-3477","volume":"25","author":"L Cai","year":"2019","unstructured":"Cai L, Michelakos T, Deshpande V, Arora KS, Yamada T, Ting DT, et al. Role of tumor-associated macrophages in the clinical course of pancreatic neuroendocrine tumors (PanNETs). Clin Cancer Res. 2019;25:2644\u201355.","journal-title":"Clin Cancer Res"},{"key":"1045_CR11","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1158\/0008-5472.CAN-04-3977","volume":"65","author":"Y Lou","year":"2005","unstructured":"Lou Y, Vitalis TZ, Basha G, Cai B, Chen SS, Choi KB, et al. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res. 2005;65:7926\u201333.","journal-title":"Cancer Res"},{"key":"1045_CR12","doi-asserted-by":"publisher","first-page":"26562","DOI":"10.1074\/jbc.M115.676130","volume":"290","author":"CC Chang","year":"2015","unstructured":"Chang CC, Pirozzi G, Wen SH, Chung IH, Chiu BL, Errico S, et al. Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy. J Biol Chem. 2015;290:26562\u201375.","journal-title":"J Biol Chem"},{"key":"1045_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4389-3","volume":"18","author":"BJ Morrison","year":"2018","unstructured":"Morrison BJ, Steel JC, Morris JC. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells. BMC Cancer. 2018;18:469.","journal-title":"BMC Cancer"},{"key":"1045_CR14","doi-asserted-by":"publisher","first-page":"9601","DOI":"10.1158\/0008-5472.CAN-07-5270","volume":"68","author":"AF Setiadi","year":"2008","unstructured":"Setiadi AF, Omilusik K, David MD, Seipp RP, Hartikainen J, Gopaul R, et al. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. Cancer Res. 2008;68:9601\u20137.","journal-title":"Cancer Res"},{"key":"1045_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/icb.2011.96","volume":"90","author":"KV Woan","year":"2012","unstructured":"Woan KV, Sahakian E, Sotomayor EM, Seto E, Villagra A. Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer. Immunol Cell Biol. 2012;90:55\u201365.","journal-title":"Immunol Cell Biol"},{"key":"1045_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Disco. 2014;13:673\u201391.","journal-title":"Nat Rev Drug Disco"},{"key":"1045_CR17","first-page":"1284","volume":"171","author":"MJ Topper","year":"2017","unstructured":"Topper MJ, Vaz M, Chiappinelli KB, DeStefano Shields CE, Niknafs N, Yen RC, et al. Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung. Cancer Cell. 2017;171:1284\u20131300.","journal-title":"Cancer Cell"},{"key":"1045_CR18","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.1128\/MCB.01547-07","volume":"27","author":"AF Setiadi","year":"2007","unstructured":"Setiadi AF, David MD, Seipp RP, Hartikainen JA, Gopaul R, Jefferies WA. Epigenetic control of the immune escape mechanisms in malignant carcinomas. Mol Cell Biol. 2007;27:7886\u201394.","journal-title":"Mol Cell Biol"},{"key":"1045_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/j.1460-2075.1988.tb02909.x","volume":"7","author":"R Versteeg","year":"1988","unstructured":"Versteeg R, Noordermeer IA, Kr\u00fcse-Wolters M, Ruiter DJ, Schrier PI. c-myc down-regulates class I HLA expression in human melanomas. EMBO J. 1988;7:1023\u20139.","journal-title":"EMBO J"},{"key":"1045_CR20","doi-asserted-by":"crossref","first-page":"41505","DOI":"10.18632\/oncotarget.9214","volume":"7","author":"W Yang","year":"2016","unstructured":"Yang W, Yu H, Shen Y, Liu Y, Yang Z, Sun T. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR\/lincRNA-p21\/\u03b2-catenin pathway. Oncotarget. 2016;7:41505\u201326.","journal-title":"Oncotarget"},{"key":"1045_CR21","unstructured":"Wong TS, Chen S, Zhang MJ, Chan JY, Gao W. Epstein-Barr virus-encoded microRNA BART7 downregulates major histocompatibilitycomplex class I chain-related peptide A and reduces the cytotoxicity of natural killer cells to nasopharyngeal carcinoma. Oncol Lett. 2018; 16:2887\u201392."},{"key":"1045_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3359","volume":"4","author":"B Wang","year":"2013","unstructured":"Wang B, Niu D, Lai L, Ren EC. p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1. Nat Commun. 2013;4:2359.","journal-title":"Nat Commun"},{"key":"1045_CR23","doi-asserted-by":"publisher","first-page":"7740","DOI":"10.1038\/sj.onc.1203235","volume":"18","author":"K Zhu","year":"1999","unstructured":"Zhu K, Wang J, Zhu J, Jiang J, Shou J, Chen X. p53 induces TAP1 and enhances the transport of MHC class I peptides. Oncogene. 1999;18:7740\u20137.","journal-title":"Oncogene"},{"key":"1045_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1349-7006.2006.00208.x","volume":"97","author":"T Szatm\u00e1ri","year":"2006","unstructured":"Szatm\u00e1ri T, Lumniczky K, D\u00e9saknai S, Trajcevski S, H\u00eddv\u00e9gi EJ, Hamada H, et al. Detailed characterization of the mouse glioma 261 tumor model experimental glioblastomatherapy. Cancer Sci. 2006;97:546\u201353.","journal-title":"Cancer Sci"},{"key":"1045_CR25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.canlet.2017.12.005","volume":"415","author":"W Yang","year":"2018","unstructured":"Yang W, Liu Y, Gao R, Yu H, Sun T. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH\/Gli1 signaling pathway. Cancer Lett. 2018;415:164\u201376.","journal-title":"Cancer Lett"},{"key":"1045_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2019.01.006","volume":"35","author":"A Carugo","year":"2019","unstructured":"Carugo A, Minelli R, Sapio L, Soeung M, Carbone F, Robinson FS, et al. p53 is a master regulator of proteostasis in SMARCB1-deficient malignant rhabdoid tumors. Cancer Cell. 2019;35:204\u201320.","journal-title":"Cancer Cell"},{"key":"1045_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2018.00014","volume":"9","author":"A Durgeau","year":"2018","unstructured":"Durgeau A, Virk Y, Corgnac S, Mami-Chouaib F. Recent advances in targeting cd8 T-cell immunity for more effective cancer immunotherapy. Front Immunol. 2018;9:14.","journal-title":"Front Immunol"},{"key":"1045_CR28","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa051424","volume":"353","author":"F Pages","year":"2005","unstructured":"Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654\u201366.","journal-title":"N Engl J Med"},{"key":"1045_CR29","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/j.vaccine.2006.11.064","volume":"25","author":"Y Lou","year":"2007","unstructured":"Lou Y, Seipp RP, Cai B, Chen SS, Vitalis TZ, Choi KB, et al. Tumour immunity and T cell memory are induced by low dose inoculation with a non-replicating adenovirus encoding TAP1. Vaccine. 2007;25:2331\u20139.","journal-title":"Vaccine"},{"key":"1045_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00262-015-1754-9","volume":"65","author":"G Finocchiaro","year":"2016","unstructured":"Finocchiaro G, Pellegatta S. Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies. Cancer Immunol Immunother. 2016;65:101\u20139.","journal-title":"Cancer Immunol Immunother"},{"key":"1045_CR31","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00262-013-1453-3","volume":"62","author":"EO Vik-Mo","year":"2013","unstructured":"Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC, Due-T\u00f8nnesen P, Suso EM, et al. Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma. Cancer Immunol Immunother. 2013;62:1499\u2013509.","journal-title":"Cancer Immunol Immunother"},{"key":"1045_CR32","doi-asserted-by":"crossref","first-page":"74451","DOI":"10.18632\/oncotarget.20165","volume":"8","author":"T Sun","year":"2017","unstructured":"Sun T, Wu H, Li Y, Huang Y, Yao L, Chen X, et al. Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy. Oncotarget. 2017;8:74451\u201365.","journal-title":"Oncotarget"},{"key":"1045_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10014-013-0149-x","volume":"31","author":"H Sadahiro","year":"2014","unstructured":"Sadahiro H, Yoshikawa K, Ideguchi M, Kajiwara K, Ishii A, Ikeda E, et al. Pathological features of highly invasive glioma stem cells in a mouse xenograft model. Brain Tumor Pathol. 2014;31:77\u201384.","journal-title":"Brain Tumor Pathol"},{"key":"1045_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.yexcr.2014.05.022","volume":"326","author":"W Yang","year":"2014","unstructured":"Yang W, Wei J, Guo T, Shen Y, Liu F. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance. Exp Cell Res. 2014;326:22\u201335.","journal-title":"Exp Cell Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-1045-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-1045-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-019-1045-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T10:41:30Z","timestamp":1695292890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-019-1045-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,1,30]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1038\/s41388-019-1045-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]},"assertion":[{"value":"26 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}